Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vance G Fowler

Showing results (61-70 of 425) with videos related to

Pageof 43
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Efficient Delivery of Investigational Antibacterial Agents via Sustainable Clinical Trial NetworksAnthony McDonnell, John H Rex, Herman Goossens, et al.
Plos One|April 9, 2013
Host gene expression profiling and in vivo cytokine studies to characterize the role of linezolid and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) murine sepsis modelBatu K Sharma-Kuinkel, Yurong Zhang, Qin Yan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2023
Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients With Staphylococcus aureus BacteremiaTori Kinamon, Michael Dagher, Lawrence Park, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Antimicrobial activity of prosthetic heart valve sewing cuffs coated with minocycline and rifampinRabih O Darouiche, Vance G Fowler, Karim Adal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
Transforming Concepts Into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership GroupHeather R Cross, Anthony Harris, Rebekka M Arias, et al.
FEMS Microbiology Reviews|December 17, 2019
Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanismsLloyd S Miller, Vance G Fowler, Sanjay K Shukla, et al.
Archives of Internal Medicine|February 29, 2012
Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008Jerome J Federspiel, Sally C Stearns, Amanda F Peppercorn, et al.
The Journal of Infectious Diseases|May 31, 2022
Heterogeneity in Staphylococcus aureus Bacteraemia Clinical Trials Complicates Interpretation of FindingsHeather W Dolby, Sarah A Clifford, Ian F Laurenson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2016
MASTERMIND: Bringing Microbial Diagnostics to the ClinicRobin Patel, Ephraim L Tsalik, Elizabeth Petzold, et al.
The Journal of Biological Chemistry|January 6, 2012
Dissociation rate constants of human fibronectin binding to fibronectin-binding proteins on living Staphylococcus aureus isolated from clinical patientsNadia N Casillas-Ituarte, Brian H Lower, Supaporn Lamlertthon, et al.
Pageof 43

Showing results (61-70 of 425) with videos related to

Sort By:
Pageof 43
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Efficient Delivery of Investigational Antibacterial Agents via Sustainable Clinical Trial NetworksAnthony McDonnell, John H Rex, Herman Goossens, et al.
Plos One|April 9, 2013
Host gene expression profiling and in vivo cytokine studies to characterize the role of linezolid and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) murine sepsis modelBatu K Sharma-Kuinkel, Yurong Zhang, Qin Yan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2023
Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients With Staphylococcus aureus BacteremiaTori Kinamon, Michael Dagher, Lawrence Park, et al.
Antimicrobial Agents and Chemotherapy|January 18, 2002
Antimicrobial activity of prosthetic heart valve sewing cuffs coated with minocycline and rifampinRabih O Darouiche, Vance G Fowler, Karim Adal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2017
Transforming Concepts Into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership GroupHeather R Cross, Anthony Harris, Rebekka M Arias, et al.
FEMS Microbiology Reviews|December 17, 2019
Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanismsLloyd S Miller, Vance G Fowler, Sanjay K Shukla, et al.
Archives of Internal Medicine|February 29, 2012
Increasing US rates of endocarditis with Staphylococcus aureus: 1999-2008Jerome J Federspiel, Sally C Stearns, Amanda F Peppercorn, et al.
The Journal of Infectious Diseases|May 31, 2022
Heterogeneity in Staphylococcus aureus Bacteraemia Clinical Trials Complicates Interpretation of FindingsHeather W Dolby, Sarah A Clifford, Ian F Laurenson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 9, 2016
MASTERMIND: Bringing Microbial Diagnostics to the ClinicRobin Patel, Ephraim L Tsalik, Elizabeth Petzold, et al.
The Journal of Biological Chemistry|January 6, 2012
Dissociation rate constants of human fibronectin binding to fibronectin-binding proteins on living Staphylococcus aureus isolated from clinical patientsNadia N Casillas-Ituarte, Brian H Lower, Supaporn Lamlertthon, et al.
Pageof 43